MINERALOCORTICOID RECEPTOR ANTAGONISM IN CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Gillis, Keith [1 ]
Lees, Jennifer [2 ]
Jardine, Alan [2 ]
Traynor, Jamie [1 ]
Mark, Patrick [2 ]
机构：
[1] Queen Elizabeth Univ Hosp, Glasgow Renal & Transplant Unit, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MP111
引用
收藏
页码：468 / 469
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety assessment of mineralocorticoid receptor antagonists in patients with chronic kidney disease
    Ding, Kaiyue
    Li, Zhuoyu
    Lu, Yingying
    Sun, Lin
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 115 : 114 - 127
  • [32] Effects of Chronic Kidney Disease on Nanomechanics of the Endothelial Glycocalyx Are Mediated by the Mineralocorticoid Receptor
    Fels, Benedikt
    Beyer, Arne
    Cazana-Perez, Violeta
    Giraldez, Teresa
    Navarro-Gonzalez, Juan F.
    de la Rosa, Diego Alvarez
    Schaefer, Franz
    Bayazit, Aysun K.
    Obrycki, Lukasz
    Ranchin, Bruno
    Holle, Johannes
    Querfeld, Uwe
    Kusche-Vihrog, Kristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [33] Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome
    Miki Nagase
    Clinical and Experimental Nephrology, 2010, 14 : 303 - 314
  • [34] Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease
    Akira Nishiyama
    Hypertension Research, 2019, 42 : 293 - 300
  • [35] Mineralocorticoid receptor antagonists: part of an emerging treatment paradigm for chronic kidney disease
    Epstein, Murray
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (12): : 925 - 927
  • [36] Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome
    Nagase, Miki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (04) : 303 - 314
  • [37] Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease
    Nishiyama, Akira
    HYPERTENSION RESEARCH, 2019, 42 (03) : 293 - 300
  • [38] Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
    Kovarik, Johannes J.
    Kaltenecker, Christopher C.
    Domenig, Oliver
    Antlanger, Marlies
    Poglitsch, Marko
    Kopecky, Chantal
    Saemann, Marcus D.
    DIABETES THERAPY, 2021, 12 (09) : 2485 - 2498
  • [39] Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
    Johannes J. Kovarik
    Christopher C. Kaltenecker
    Oliver Domenig
    Marlies Antlanger
    Marko Poglitsch
    Chantal Kopecky
    Marcus D. Säemann
    Diabetes Therapy, 2021, 12 : 2485 - 2498
  • [40] Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
    Kawanami, Daiji
    Takashi, Yuichi
    Muta, Yoshimi
    Oda, Naoki
    Nagata, Dai
    Takahashi, Hiroyuki
    Tanabe, Makito
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345